Author

David S. Fam

Institution: Tris Pharma (United States)

Observed institution: Tris Pharma (United States)

OpenAlex ID: A5113385576

Measuring the Effect of Amphetamine Extended-Release (DYANAVEL® XR) on Driving Performance in Young Adult Drivers with ADHD Using a Sophisticated Driving Simulation

2026 · Craig Surman, Bruce Mehler, et al. · Advances in Therapy

The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States

2026 · James C. Hackworth, John E. Schneider, et al. · Frontiers in Public Health

Works count: 2

Citation count:

H-index:

I10-index: